throbber
Paper No. __
`Filed: January 29, 2015
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS, LLC, AND
`PAR PHARMACEUTICAL, INC.
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`Patent Owner
`
`________________
`
`Case IPR2015-00545
`Patent 8,589,182
`________________
`
`MANDATORY NOTICES BY JAZZ PHARMACEUTICALS, INC.
`UNDER 35 U.S.C. §§ 311-319 AND 37 C.F.R. §§ 42.8, 42.100 ET. SEQ.
`
`
`
`
`
`

`
`Case IPR2015-00545
`Patent 8,589,182
`Patent Owner Mandatory Notices
`
`
`REAL PARTY-IN-INTEREST
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(b)(1), the undersigned state
`
`that Jazz Pharmaceuticals, Inc. (“Jazz Pharmaceuticals”) is the real party-in-
`
`interest. Jazz Pharmaceuticals is a corporation organized and existing under the
`
`laws of the State of Delaware, having a principal place of business at 3180 Porter
`
`Drive, Palo Alto, California 94304. Jazz Pharmaceuticals owns by assignment the
`
`entire right, title, and interest in U.S. Patent No. 8,589,182 (the “’182 patent”) by
`
`virtue of an Assignment of rights from the inventors, Dayton Reardon, Patti Engle
`
`and Bob Gagne. The Assignment was recorded with the United States Patent and
`
`Trademark Office on December 22, 2010, at Reel 025604, Frame 0903, in
`
`connection with the application that issued as U.S. Patent No. 7,668,730, of which
`
`the application that led to the ’182 patent was a continuation thereof.
`
`RELATED MATTERS
`
`Pursuant to 37 C.F.R. § 42.8(b)(2), the undersigned state that the ’182 patent
`
`is the subject of four, currently-pending litigations: Jazz Pharmaceuticals, Inc. v.
`
`Amneal Pharmaceuticals, LLC and Par Pharmaceutical, Inc., 2:13-cv-391
`
`(consolidated) (D.N.J.); Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals,
`
`LLC, 2:14-cv-3235 (D.N.J.); Jazz Pharmaceuticals, Inc. v. Ranbaxy Laboratories
`
`Ltd., et al., 2:14-cv-4467 (D.N.J.); and Jazz Pharmaceuticals, Inc. v. Watson
`
`
`
`

`
`Case IPR2015-00545
`Patent 8,589,182
`Patent Owner Mandatory Notices
`
`
`Laboratories, Inc., 2:14-cv-7757 (D.N.J). Two other litigations, Jazz
`
`Pharmaceuticals, Inc. v. Roxane Laboratories, Inc., 2:10-cv-6108 (D.N.J.) and
`
`Jazz Pharmaceuticals, Inc. v. Par Pharmaceutical, Inc., 2:14-cv-5139 (D.N.J.),
`
`concern patents related to the ’182 patent.
`
`Additionally, one or more of the Petitioners have filed for inter partes
`
`review of five related patents: U.S. Patent No. 7,895,059 (IPR2015-00548); U.S.
`
`Patent No. 8,457,988 (IPR2015-00551); U.S. Patent No. 7,668,730 (IPR2015-
`
`00554); U.S. Patent No. 7,765,106 (IPR2015-00546); and U.S. Patent No.
`
`7,765,107 (IPR2015-00547).
`
`One or more of the Petitioners have also previously filed for covered
`
`business method review of the ’182 patent (CBM2014-00153) and the above-
`
`identified related patents: U.S. Patent No. 7,895,059 (CBM2014-00149); U.S.
`
`Patent No. 8,457,988 (CBM2014-00150); U.S. Patent No. 7,668,730 (CBM2014-
`
`00151); U.S. Patent No. 7,765,106 (CBM2014-00161); and U.S. Patent No.
`
`7,765,107 (CBM2014-00175). On January 13, 2015, the Patent Trial and Appeal
`
`Board (the “Board”) denied institution of covered business method review of the
`
`’182 patent in CBM2014-00153, as well as the patents involved in CBM2014-
`
`00149, CBM2014-00150 and CBM2014-00151. See CBM2014-00149 at Paper
`
`
`
`

`
`Case IPR2015-00545
`Patent 8,589,182
`Patent Owner Mandatory Notices
`
`
`12. The Board has yet to issue a decision on institution in CBM2014-00161 and
`
`CBM2014-00175.
`
`Further, the following pending U.S. Patent applications claim the benefit of
`
`U.S. Patent Application No. 10/322,348, which the ’182 patent also claims the
`
`benefit of: U.S. Patent Application No. 14/196,603, filed on March 4, 2014, U.S.
`
`Patent Application No. 14/219,904, filed on March 19, 2014, and U.S. Patent
`
`Application No. 14/219,941 filed on March 19, 2014.
`
`LEAD COUNSEL AND BACK-UP COUNSEL (37 C.F.R. § 42.8(b)(3))
`
`Lead Counsel:
`
`
`
`F. Dominic Cerrito (Reg. No. 38,100)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: nickcerrito@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`Back-Up Counsel:
`
`John V. Biernacki (Reg. No. 40,511)
`
`Contact Information:
`
`Jones Day
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`North Point
`
`901 Lakeside Avenue
`
`Cleveland, OH 44114
`
`
`
`
`
`
`
`
`
`

`
`Case IPR2015-00545
`Patent 8,589,182
`Patent Owner Mandatory Notices
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Email: jvbiernacki@jonesday.com
`
`Telephone: 216-586-3939
`
`SERVICE INFORMATION
`
`Pursuant to 37 C.F.R. § 42.8(b)(4), please direct all correspondence to lead
`
`and back-up counsel at the above addresses. Patent Owner consents to email
`
`service at the above-specified email addresses.
`
`Date: January 29, 2015
`
`
`
`
`
`
`Respectfully submitted,
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito
` Reg. No. 38,100
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Direct Tel: (212) 849-7450
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`John V. Biernacki
`Reg. No. 40,511
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`General Tel: (216) 586-3939
`Direct Tel: (216) 586-7747
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`Attorneys for Jazz Pharmaceuticals, Inc.
`
`
`
`

`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS, LLC, AND
`PAR PHARMACEUTICAL, INC.
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`Patent Owner
`
`________________
`
`Case IPR2015-00545
`Patent 8,589,182
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`

`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certify that
`
`MANDATORY NOTICES BY JAZZ PHARMACEUTICALS, INC. and the
`
`attached POWER OF ATTORNEY and 3.73(b) STATEMENT were served on
`
`January 29, 2015 by filing these documents through the Patent Review Processing
`
`System, as well as e-mailing copies to dvarughe-PTAB@skgf.com and dsterlin-
`
`PTAB@skgf.com.
`
`Date: January 29, 2015
`
`
`
`
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito
` Reg. No. 38,100
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Direct Tel: (212) 849-7450
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`John V. Biernacki
`Reg. No. 40,511
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`General Tel: (216) 586-3939
`Direct Tel: (216) 586-7747
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`Attorneys for Jazz Pharmaceuticals, Inc.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket